248 related articles for article (PubMed ID: 12231548)
1. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.
Silber JR; Bobola MS; Blank A; Schoeler KD; Haroldson PD; Huynh MB; Kolstoe DD
Clin Cancer Res; 2002 Sep; 8(9):3008-18. PubMed ID: 12231548
[TBL] [Abstract][Full Text] [Related]
2. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
4. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas.
Bobola MS; Blank A; Berger MS; Stevens BA; Silber JR
Clin Cancer Res; 2001 Nov; 7(11):3510-8. PubMed ID: 11705870
[TBL] [Abstract][Full Text] [Related]
5. CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.
Kaur S; Ramdzan ZM; Guiot MC; Li L; Leduy L; Ramotar D; Sabri S; Abdulkarim B; Nepveu A
Neuro Oncol; 2018 Mar; 20(4):484-493. PubMed ID: 29036362
[TBL] [Abstract][Full Text] [Related]
6. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors.
Rai G; Vyjayanti VN; Dorjsuren D; Simeonov A; Jadhav A; Wilson DM; Maloney DJ
J Med Chem; 2012 Apr; 55(7):3101-12. PubMed ID: 22455312
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
9. Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy.
Bobola MS; Emond MJ; Blank A; Meade EH; Kolstoe DD; Berger MS; Rostomily RC; Silbergeld DL; Spence AM; Silber JR
Clin Cancer Res; 2004 Dec; 10(23):7875-83. PubMed ID: 15585620
[TBL] [Abstract][Full Text] [Related]
10. Creation of a fully functional human chimeric DNA repair protein. Combining O6-methylguanine DNA methyltransferase (MGMT) and AP endonuclease (APE/redox effector factor 1 (Ref 1)) DNA repair proteins.
Hansen WK; Deutsch WA; Yacoub A; Xu Y; Williams DA; Kelley MR
J Biol Chem; 1998 Jan; 273(2):756-62. PubMed ID: 9422728
[TBL] [Abstract][Full Text] [Related]
11. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR
Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865
[TBL] [Abstract][Full Text] [Related]
13. Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.
Bapat A; Glass LS; Luo M; Fishel ML; Long EC; Georgiadis MM; Kelley MR
J Pharmacol Exp Ther; 2010 Sep; 334(3):988-98. PubMed ID: 20504914
[TBL] [Abstract][Full Text] [Related]
14. Human glioma cell sensitivity to the sequence-specific alkylating agent methyl-lexitropsin.
Bobola MS; Varadarajan S; Smith NW; Goff RD; Kolstoe DD; Blank A; Gold B; Silber JR
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):612-20. PubMed ID: 17255284
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide: mechanisms of action, repair and resistance.
Zhang J; Stevens MF; Bradshaw TD
Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
[TBL] [Abstract][Full Text] [Related]
16. Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation.
Hsieh MM; Hegde V; Kelley MR; Deutsch WA
Nucleic Acids Res; 2001 Jul; 29(14):3116-22. PubMed ID: 11452037
[TBL] [Abstract][Full Text] [Related]
17. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents.
McNeill DR; Wilson DM
Mol Cancer Res; 2007 Jan; 5(1):61-70. PubMed ID: 17259346
[TBL] [Abstract][Full Text] [Related]
18. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1.
Kelley MR; Parsons SH
Antioxid Redox Signal; 2001 Aug; 3(4):671-83. PubMed ID: 11554453
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.
Tentori L; Portarena I; Torino F; Scerrati M; Navarra P; Graziani G
Glia; 2002 Oct; 40(1):44-54. PubMed ID: 12237842
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
